(19)
(11) EP 1 597 582 A2

(12)

(88) Date of publication A3:
17.06.2004

(43) Date of publication:
23.11.2005 Bulletin 2005/47

(21) Application number: 03779825.3

(22) Date of filing: 31.10.2003
(51) International Patent Classification (IPC)7: G01N 33/573, A61K 38/00, A61K 38/43
(86) International application number:
PCT/EP2003/012120
(87) International publication number:
WO 2004/044589 (27.05.2004 Gazette 2004/22)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 13.11.2002 EP 02025501

(71) Applicant: Bayer HealthCare AG
51368 Leverkusen (DE)

(72) Inventors:
  • GOLZ, Stefan
    45326 Essen (DE)
  • BRÜGGEMEIER, Ulf
    42799 Leichlingen (DE)
  • SUMMER, Holger
    42113 Wuppertal (DE)

   


(54) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN ENDOTHELIAL DIFFERENTIATION, SPHINGOLIPID G-PROTEIN-COUPLED RECEPTOR 3 (EDG3)